During the last session, Atossa Therapeutics Inc (NASDAQ:ATOS)’s traded shares were 1.86 million, with the beta value of the company hitting 1.28. At the end of the trading day, the stock’s price was $1.50, reflecting an intraday gain of 0.67% or $0.01. The 52-week high for the ATOS share is $2.31, that puts it down -54.0 from that peak though still a striking 60.67% gain since the share price plummeted to a 52-week low of $0.59. The company’s market capitalization is $187.95M, and the average trade volume was 1.64 million shares over the past three months.
Atossa Therapeutics Inc (NASDAQ:ATOS) trade information
Atossa Therapeutics Inc (ATOS) registered a 0.67% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.67% in intraday trading to $1.50, hitting a weekly high. The stock’s 5-day price performance is 11.11%, and it has moved by -20.63% in 30 days. Based on these gigs, the overall price performance for the year is 123.21%.
Atossa Therapeutics Inc (ATOS) estimates and forecasts
Statistics show that Atossa Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. Atossa Therapeutics Inc (ATOS) shares have gone up 127.27% during the last six months, with a year-to-date growth rate less than the industry average at -16.67% against 14.60. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -20.00% this quarter and then jump 25.00% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 46.61%. While earnings are projected to return -13.89% in 2024.
ATOS Dividends
Atossa Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
